Literature DB >> 25656495

Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome.

Dorte Glintborg1, Katrine Hass Rubin2, Mads Nybo2, Bo Abrahamsen2, Marianne Andersen2.   

Abstract

OBJECTIVE: The prevalence of type 2 diabetes is increased in polycystic ovary syndrome (PCOS), but the prevalence of other diseases is not clarified. We aimed to investigate morbidity and medicine prescriptions in PCOS.
DESIGN: A National Register-based study.
METHODS: Patients with PCOS (PCOS Denmark and an embedded cohort; PCOS Odense University Hospital (OUH)) and one control population. Premenopausal women with PCOS underwent clinical and biochemical examination (PCOS OUH, n=1217). PCOS Denmark (n=19 199) included women with PCOS in the Danish National Patient Register. Three age-matched controls were included per patient (n=57 483). MAIN OUTCOME MEASURES: Diagnosis codes and filled prescriptions.
RESULTS: The mean (range) age of the PCOS Denmark group and controls was 30.6 (12-60) years. Patients in PCOS Denmark had higher Charlson index, higher prevalence of diabetes, dyslipidemia, and hypertension than controls. PCOS was associated with a two times increased risk of stroke and thrombosis, whereas the risk of other cardiovascular diseases was not increased. Thyroid disease, asthma, migraine, and depression were more prevalent in PCOS Denmark vs controls, whereas fractures were rarer. Infertility was increased in patients compared with controls, but the mean number of births was higher in PCOS. Medicine prescriptions within all diagnosis areas were significantly higher in PCOS patients than in controls.In PCOS OUH, polycystic ovaries (PCO) and irregular menses were associated with a more adverse metabolic risk profile, but individual Rotterdam criteria were not associated with cardiometabolic diagnoses.
CONCLUSION: Cardiometabolic and psychiatric morbidity were significantly increased in a Danish population with PCOS. Medical diseases are frequent also in young patients with PCOS.
© 2015 European Society of Endocrinology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25656495     DOI: 10.1530/EJE-14-1108

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  33 in total

Review 1.  Insulin resistance and PCOS: chicken or egg?

Authors:  P Moghetti; F Tosi
Journal:  J Endocrinol Invest       Date:  2020-07-09       Impact factor: 4.256

2.  Prenatal Androgen Exposure and Traits of Autism Spectrum Disorder in the Offspring: Odense Child Cohort.

Authors:  Camilla V B Palm; Dorte Glintborg; Laura G Find; Pia V Larsen; Cilia M Dalgaard; Henriette Boye; Tina K Jensen; Anja F Dreyer; Marianne S Andersen; Niels Bilenberg
Journal:  J Autism Dev Disord       Date:  2022-02-06

Review 3.  Is there any association between migraine headache and polycystic ovary syndrome (PCOS)? A review article.

Authors:  Nahid Sarahian; Mahsa Noroozzadeh; Marzieh Saei Ghare Naz; Narges Eskandari-Roozbahani; Fatemeh Mahboobifard; Fahimeh Ramezani Tehrani
Journal:  Mol Biol Rep       Date:  2021-10-15       Impact factor: 2.316

Review 4.  Prospective Risk of Type 2 Diabetes in Normal Weight Women with Polycystic Ovary Syndrome.

Authors:  Dorte Glintborg; Naja Due Kolster; Pernille Ravn; Marianne Skovsager Andersen
Journal:  Biomedicines       Date:  2022-06-20

5.  Role of Oxidative Stress in Obese and Nonobese PCOS Patients.

Authors:  Kazım Uçkan; Halit Demir; Kasım Turan; Eren Sarıkaya; Canan Demir
Journal:  Int J Clin Pract       Date:  2022-02-09       Impact factor: 3.149

Review 6.  Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives.

Authors:  Yue Xu; Zhi-Yang Zhou; Jie-Xue Pan; He-Feng Huang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

7.  Self-Reported Polycystic Ovary Syndrome Is Associated With Hypertension: A Northern Finland Birth Cohort 1966 Study.

Authors:  Meri-Maija E Ollila; Kari Kaikkonen; Marjo-Riitta Järvelin; Heikki V Huikuri; Juha S Tapanainen; Stephen Franks; Terhi T Piltonen; Laure Morin-Papunen
Journal:  J Clin Endocrinol Metab       Date:  2019-04-01       Impact factor: 5.958

8.  Clinical and biochemical signs of polycystic ovary syndrome in young women born preterm.

Authors:  Marika Paalanne; Marja Vääräsmäki; Sanna Mustaniemi; Marjaana Tikanmäki; Karoliina Wehkalampi; Hanna-Maria Matinolli; Johan Eriksson; Marjo-Riitta Järvelin; Laure Morin-Papunen; Eero Kajantie
Journal:  Eur J Endocrinol       Date:  2021-07-01       Impact factor: 6.664

9.  Associations between metabolic disorders and risk of cancer in Danish men and women--a nationwide cohort study.

Authors:  Siv Mari Berger; Gunnar Gislason; Lynn L Moore; Charlotte Andersson; Christian Torp-Pedersen; Gerald V Denis; Michelle Dalgas Schmiegelow
Journal:  BMC Cancer       Date:  2016-02-22       Impact factor: 4.430

10.  Diagnosis and management of polycystic ovary syndrome in the UK (2004-2014): a retrospective cohort study.

Authors:  Tao Ding; Gianluca Baio; Paul J Hardiman; Irene Petersen; Cormac Sammon
Journal:  BMJ Open       Date:  2016-07-11       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.